Conference abstract · 24 Aug 2015
Conference abstractPublished 24 Aug 2015
Genetic toxicity screening assays
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In drug development, genotoxicity testing is an essential part of preclinical safety evaluation. Before a potential drug candidate is selected, many chemicals have to go through pre-screening in drug discovery/lead optimization to weed out any “bad actors”. Non-GLP assays used at early stages to select candidates for further development as they have lower cost, quick turnaround time, minimal test article requirement. However, these assays should be predictive of the standard GLP assays. For impurities that are not feasible to isolate or synthesize or when compound quantity is limited, it may not be possible to achieve the highest test concentrations recommended for an ICH-compliant bacterial mutagenicity assay according to the current testing guidelines. In this case, bacterial mutagenicity testing could be carried out using a miniaturized assay format with proven high concordance to the ICH-compliant assay to enable testing at higher concentrations with justification. Virtually any regulatory assay can be scaled down to conserve test article, time and money by using fewer dose levels, replicates, strains or animals. Also in some cases fewer cells are scored. For Ames assay, modifications of the standard assays (e.g., 24-well, 6 well methods) or different techniques with good predictive qualities (e.g., Ames II assay with liquid format) are available. For cytogenetics assay, modified designs with either reduced scoring or reduced culture size are offered. Different designs and the pros and cons of these design modifications will be discussed during the workshop.
Subjects
ToxicologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Aug 2015
Genetic toxicity screening assays
Conference abstract · 2015
Genetic toxicity screening assays
Conference abstract · 17 Oct 2016
Effluent toxicity assay of wastewater treatment plant using Daphnia magna and its relation to physicochemical parameters
Conference abstract · 7 Oct 2013
In vitro molecular hematopoietic assays as substitute of in vivo tests in regulatory toxicity study of drugs
More from this journal
The newest in Journal of Clinical Toxicology.
Commentary · 8 Apr 2026
Occupational Chlorfenapyr Poisoning: Clinical Implications and Research Value Under Hidden Risks
Perspective · 25 Feb 2026
Toxicological and Health Effects: Mechanisms, Exposure Routes and Prevention Strategies
Case report · 23 Feb 2026
Case Report: Methaemoglobinaemia Following Indoxacarb Ingestion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Toxicology
- SubjectToxicology
- BylineArticles whose byline prints “Kamala Pant”

